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Like many positive-strand RNA viruses, brome mosaic virus (BMV) RNA replication occurs in membrane-
invaginated vesicular compartments. BMV RNA replication compartments show parallels with membrane-
enveloped, budding retrovirus virions, whose release depends on the cellular multivesicular body (MVB)
sorting pathway. BMV RNA replication compartments are not released from their parent membranes, but
might depend on MVB functions for membrane invagination. Prior results show that BMV RNA replication is
severely inhibited by deletion of the crucial MVB gene DOA4 or BRO1. We report here that involvement of
DOA4 and BRO1 in BMV RNA replication is not dependent on the MVB pathway’s membrane-shaping
functions but rather is due to their roles in recycling ubiquitin from MVB cargos. We show that deleting DOA4
or BRO1 inhibits the ubiquitination- and proteasome-dependent activation of homologous transcription fac-
tors Mga2p and Spt23p, which regulate many lipid metabolism genes, including the fatty acid desaturase gene
OLE1, which is essential for BMV RNA replication. However, Mga2p processing and BMV RNA replication are
restored by supplementing free ubiquitin, which is depleted in doa4 and bro1 cells. The results identify
Mga2p and Spt23p processing and lipid regulation as sensitive targets of ubiquitin depletion and correctly
predict multiple effects of modulating additional host genes RFU1, UBP6, and UFD3. Our results also show
that BMV RNA replication depends on additional Mga2p-regulated genes likely involved in lipid metabolism
beyond OLE1. Among other points, these findings show the potential for blocking viral RNA replication by
modulating lipid synthesis at multiple levels.
Positive-strand RNA viruses replicate their RNA genomes
in close association with proliferated and rearranged host in-
tracellular membranes (17, 47, 62). Accordingly, lipid synthesis
and the lipid composition of intracellular membranes play
important roles in RNA replication by many positive-strand
RNA viruses (12, 13, 16, 23, 32, 38–40, 64, 66, 72–74).
Revealing the critical interactions between membrane rear-
rangement, lipid synthesis/composition, and viral RNA rep-
lication will further understanding of viral replication and
could provide foundations for novel broad-spectrum antivi-
ral strategies.
Brome mosaic virus (BMV) has been used as a model system
to study gene expression, RNA replication, virus-host interac-
tion, and evolution of positive-strand RNA viruses (70). BMV
has a tripartite RNA genome and a single subgenomic mRNA,
RNA4. Genomic RNA1 and RNA2 encode the two BMV
RNA replication proteins, 1a and 2apol, respectively. 2apol con-
tains the viral RNA-dependent RNA polymerase domain. 1a,
which contains RNA capping (3, 35) and NTPase/helicase do-
mains (71), plays multiple, central roles in RNA replication
complex assembly and function. For example, 1a directs itself,
2apol, and viral RNA replication templates to perinuclear en-
doplasmic reticulum (ER) membranes that become the sites of
viral RNA synthesis both in BMV’s natural plant hosts and in
cells of the yeast Saccharomyces cerevisiae, which also support
BMV RNA replication, subgenomic mRNA transcription, and
selective RNA encapsidation (15, 18, 29, 37, 57, 58, 63). More-
over, at these perinuclear ER membranes, 1a induces forma-
tion of 60- to 75-nm spherular invaginations that serve as
RNA replication compartments in yeast (63) and in plant hosts
of BMV, such as Nicotiana benthamiana (X. Wang, A. Diaz,
and P. Ahlquist, unpublished results). Many other positive-
strand RNA viruses use similar vesicular membrane invagina-
tions as RNA replication compartments (2, 17, 36).
BMV RNA replication is closely linked not only to forma-
tion of these vesicular RNA replication compartments (19, 42)
but also to the lipid composition of the associated membranes
(38–40). For example, even though normal numbers of repli-
cation compartments form, BMV RNA replication is inhibited
by 20-fold when the activity of 9 fatty acid desaturase,
which converts saturated to monounsaturated fatty acids (SFA
and monoUFA, respectively), is reduced by mutations in yeast
(39, 40) or by gene-specific RNA interference in N. benthami-
ana plants (X. Wang et al., unpublished data).
Previously, Kushner et al. (38) screened a yeast single-gene-
deletion library and identified 100 genes whose deletion in-
hibited or enhanced BMV RNA replication by 3-fold.
Among the implicated genes, we focused on DOA4 and BRO1,
key components of the multivesicular body (MVB) pathway
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through which mono- or oligoubiquitinated cargo proteins,
such as signaling receptors, are targeted to vacuoles/lysosomes
for degradation (27, 33, 53). These cargoes are sorted into
intralumenal vesicles that invaginate away from the cytoplasm
into the endosomal lumen and then pinch off to create MVBs.
This MVB pathway is hijacked by retroviruses and other en-
veloped viruses to support their topologically similar virion
budding (10, 11, 48). For such viruses, disrupting viral recruit-
ment or function of MVB pathway components arrests the
release of budding virions at a late stage (10, 11, 48).
Before cargoes are sorted into intralumenal MVB vesicles
and degraded, ubiquitin (Ub) is obligatorily removed from
these cargoes and recycled by DOA4-encoded deubiquitinating
enzyme Doa4p (5, 6, 21, 33, 43, 69). Doa4p is also involved in
removing poly-Ub from proteins targeted for degradation by
proteasomes (50). Doa4p is recruited to MVB sites primarily
by Bro1p (4, 44, 49, 59), which also activates Doa4p’s deubiq-
uitinase activity (Fig. 1A) (59). Bro1p is the yeast ortholog of
mammalian ALX1/AIP1, through which the MVB pathway is
recruited by late domains of HIV and other retroviruses to
mediate budding (14, 46, 48). As the assembly of BMV RNA
replication complexes shares multiple similarities with budding
retroviral virions (63), we investigated whether dependence of
BMV RNA replication on DOA4 and BRO1 involved the MVB
pathway. We report here that inhibition of BMV RNA repli-
cation by deleting DOA4 or BRO1 is independent of the MVB
pathway’s membrane-shaping functions, but rather is due to
downregulated expression of 9 fatty acid desaturase and
other genes on which BMV RNA replication depends. We
further show that upon deletion of DOA4 or BRO1, a re-
duction in free Ub inhibits activation of specific transcrip-
tion factors that induce expression of 9 fatty acid desatu-
rase (Fig. 1A) and many other lipid metabolism genes. The
results further demonstrate the crucial dependence of pos-
itive-strand RNA virus replication on a balanced spectrum
of lipid synthesis and modification and the potential for
FIG. 1. Doa4p and its deubiquitinating activity are required for BMV RNA replication. (A) Schematic illustrating the connection between free
ubiquitin (Ub) levels and activation of transcription activator Mga2p (and Spt23p). Ub is removed, and thus recycled, from ubiquitinated MVB
cargoes via Doa4p or from polyubiquitinated proteasomal substrates via Ubp6p and other deubiquitinating enzymes. While Bro1p recruits Doa4p
to MVB and promotes Doa4p’s enzymatic activity, Rfu1p inhibits Doa4p activity. Mga2p (Mga2 p120) is ubiquitinated by ubiquitin ligase Rsp5p.
The C-terminal membrane-spanning domain is degraded by proteasomes, and the N-terminal activation domain (Mga2 p90) is released from
perinuclear ER membranes and subsequently targeted to the nucleus. See the text for more details. (B) The BMV RNA replication defect is
complemented (comp.) by wt Doa4p but not by the doa4C/S mutant in doa4 cells. wt DOA4 and the doa4C/S mutant were expressed from their
endogenous promoter by using centrameric plasmids. (C) BMV RNA replication is severely affected in yeast cells overexpressing RFU1. RFU1
expression was driven by the GAL1 promoter in a high-copy-number plasmid. For both panels B and C, total RNA was extracted from yeast cells
expressing BMV components. BMV positive- and negative-strand RNAs were detected by Northern blotting using probes specific to BMV RNAs.
18S rRNA bands were detected with an 18S rRNA probe. The measured BMV RNA signals were normalized to that of 18S rRNA. The blot
showing negative-strand RNA accumulation was exposed longer than that for positive-strand RNA for comparison. Total proteins were extracted
from equal numbers of yeast cells and analyzed by SDS-PAGE and immunoblot analysis with monoclonal anti-HA or anti-Pgk1p antibodies. All
experiments were done multiple times in triplicate or duplicate (Fig. 8B). Representative blots are shown for each figure.
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blocking viral replication by modulating such synthesis at
multiple levels.
MATERIALS AND METHODS
Yeast strain and cell growth. Yeast strain BY4743 and its various single-gene-
deletion derivatives were used in all experiments. Cultures were grown at 30°C in
defined synthetic medium containing 2% galactose as a carbon source. Leucine,
uracil, histidine, or combinations thereof were omitted to maintain plasmid
selection. Cells were grown in galactose medium for 2 passages (36 to 48 h) and
harvested when the optical density at 600 nm (OD600) was between 0.4 and 1.0.
To make medium supplemented with fatty acids, Tergitol NP-40 was added to a
final concentration of 1% to solubilize the fatty acids. Equimolar amounts of
palmitoleic acid (16:1) and oleic acid (18:1) were added to NP-40-containing
medium to the specified concentrations (67).
Plasmids and plasmid construction. Expression of BMV 1a and 2apol was
driven by the galactose-inducible and glucose-repressible GAL1 promoter in
most experiments. BMV 1a was expressed from plasmid pB1YT3 in all experi-
ments that did not include expression of 2apol (71). To express both 1a and 2apol
for assaying BMV RNA replication, plasmid pB12VG1 was used (38). CUP1
promoter-driven BMV RNA3 was launched from plasmid pB3VG128-H in most
experiments in medium lacking copper (38). To assay 1a-mediated RNA3 sta-
bility, we used plasmid pB3MS82, which expresses BMV RNA3 from the GAL1
promoter (68).
Wild-type [wt] DOA4 was expressed from plasmid pDOA4-8 (50) or pCR30
(59), using its endogenous promoter. The doa4C/S and doa4AAFA mutants were
expressed from pCR64 and pCR15-U, respectively (59). pCR15-U was made by
subcloning the doa4AAFA mutant sequence from pCR15 (59) to pRS416, a low-
copy-number centromeric plasmid. Ubiquitin was expressed from pYEP96-U,
which expresses the ubiquitin gene from the CUP1 promoter (22). In all exper-
iments, however, no additional copper was added to the medium. The
pYEP96-U plasmid was made by subcloning the cassette containing the copper
promoter, Ub open reading frame (ORF), and CYC1 terminator from pYEP96
(22) into pRS426, a high-copy-number 2 plasmid. Myc-tagged Mga2p and
Spt23p were expressed from 2 plasmids YEpLac181-mycMGA2 and pRS426-
mycSPT23HA, respectively (55). pRS426-mycSPT23HA was made by subcloning
the mycSPT23HA fragment from pRS416-mycSPT23HA into pRS426. A construct
overexpressing His6- and hemagglutinin (HA)-tagged RFU1 was purchased from
Open Biosystem, and the RFU1 ORF was inserted into pBG1805, a 2 plasmid
under the control of the GAL1 promoter. The bro1-2 mutant, which has an early
stop codon at position 820 amino acids (aa), was expressed from pSS41 and
pGO369 for low and high expression levels, respectively (59). The bro1-C mutant
(Bro1 aa 692 to 844) was expressed from pJEN6, a centromeric plasmid. Ex-
pression of both bro1-2 and bro1-C was driven by the endogenous promoter.
Cell fractionation assays. Yeast spheroplasts were prepared from 5 OD600
units of cells and were lysed in lysis buffer (50 mM Tris [pH 8.0], 10 mM EDTA,
10 mM dithiothreitol, and 1:200 dilution of yeast protease inhibitor mix [Sigma]).
Half of the lysate was retained as the total extracted protein. The other half of
the lysate was centrifuged at 4°C for 5 min at 20,000  g. The supernatant was
removed and retained, and the pellet was resuspended in lysis buffer. Equal
volumes of the total (T), supernatant (S), and pellet (P) fractions were used for
SDS-PAGE and Western blotting.
Western blotting. Yeast cells were grown to an OD600 of 0.4 to 1.0, and 2
OD600 units of cells was harvested. Proteins were extracted as described previ-
ously (40), and equal volumes of extracted total proteins were used for electro-
phoresis and transferred to a polyvinylidene difluoride (PVDF) membrane. Ex-
pression of target proteins was detected with the following antibodies and
dilutions: rabbit anti-BMV 1a at 1:10,000, rabbit anti-Bro1p at 1:5,000 (a gift
from Gregory Odorizzi, University of Colorado), mouse anti-BMV 2apol at
1:4,000, mouse anti-Pgk1p (A6457; Molecular Probes) at 1:10,000, mouse anti-
Dpm1p (A6429; Molecular Probes) at 1:1,000, mouse anti-Myc (OP10; Calbi-
ochem) at 1:2,000, mouse anti-Ub (P4D1; Santa Cruz Biotechnology) at 1:2,000,
and mouse anti-HA (32-6700; Invitrogen) at 1:2,000, using horseradish peroxi-
dase (HRP)-conjugated secondary antibodies and Supersignal West Femto sub-
strate (Thermo Scientific).
RESULTS
Doa4p deubiquitinase activity is required for BMV RNA
replication. A previous genomewide yeast deletion mutant
screen (38) revealed that BMV RNA replication depends on
DOA4. In that screen, a BMV RNA3 derivative expressing
Renilla luciferase (RLuc) was used as a viral RNA replication
reporter. To eliminate the possibility that the BMV replication
defect in cells with the complete DOA4 open reading frame
deleted (doa4) was specific to the Rluc reporter, we com-
pared the accumulation of BMV RNA3 replication products in
doa4 and wild-type (wt) cells expressing BMV 1a, 2apol, and
template RNA3 (Fig. 1B). Viral RNA replication and sub-
genomic mRNA synthesis were assayed by strand-specific
Northern blotting and normalized to 18S rRNA levels. In
doa4 cells, positive-strand RNA3 accumulated to only 10 to
20% and RNA4 to 5 to 10% of wt replication levels (Fig. 1B),
which agreed well with the previous Rluc-based measurements
(38). Interestingly, negative-strand RNA3 in doa4 cells was
detected at 20 to 30% of the wt level (Fig. 1B), indicating a
more moderate reduction in this earlier replication step.
The BMV RNA replication defect in doa4 cells was largely
complemented by expressing wt Doa4p (Fig. 1B). The nearly
70% complementation observed is close to the maximal pos-
sible restoration given the inevitable loss of the DOA4-express-
ing plasmid from some cells due to general inefficiencies in
plasmid segregation during mitosis (24). To determine if
Doa4p deubiquitinase activity was required for BMV RNA
replication, we used a Doa4p doa4C/S mutant, which has a
Cys7813Ser substitution that suppresses Doa4p’s deubiquiti-
nating activity (51) and its ability to support cargo protein
sorting through the MVB pathway (59). To avoid possible
nonphysiological effects from overexpression of doa4C/S (51),
as from a high-copy-number plasmid, this mutant and wt
DOA4 were independently expressed from the endogenous
DOA4 promoter on low-copy-number centromeric plasmids.
The doa4C/S mutant protein is stable in yeast (51), but in
contrast to the strong complementation by wt DOA4, expres-
sion of doa4C/S only slightly increased the low levels of BMV
RNA replication in doa4 cells (Fig. 1B). Thus, Doa4p’s deu-
biquitinase activity is essential to support BMV RNA replica-
tion.
RFU1 (regulator of free ubiquitin chains 1) was recently
identified as an inhibitor of Doa4p that helps maintain cellular
Ub homeostasis (Fig. 1A) (34). Rfu1p interacts with Doa4p
directly and inhibits Doa4p’s enzymatic activity in vitro. Over-
expression of RFU1 led to phenotypes similar to those of the
doa4 mutant, including depleted free Ub levels and heat
stress sensitivity (34; also see the next section). Therefore, we
overexpressed HA-tagged RFU1 (Rfu1p-HA) (Fig. 1C) under
the control of the strong GAL1 promoter in wt cells and
checked its effect on BMV RNA replication. Overexpressing
RFU1 inhibited BMV RNA replication by 13-fold (Fig. 1C),
independently confirming that Doa4p’s deubiquitinating activ-
ity is indeed required to support BMV RNA replication.
BMV RNA replication is restored in doa4 cells by added
Ub. In addition to defects in MVB cargo protein sorting, de-
letion of DOA4 leads to depletion of free Ub, defective protein
proteolysis in proteasomes and vacuoles/lysosomes, hypersen-
sitivity to stress and amino acid analogs, and a strong sporu-
lation defect (69). The Ub deficiency causes the remaining
listed defects since supplementation with Ub largely restores
the majority of affected functions (69). As expected, Western
blotting confirmed an equivalent decrease in free Ub in the
doa4 cells used here (Fig. 2A).
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To determine whether this free Ub deficiency played a role
in inhibiting BMV RNA replication in doa4 cells, Ub was
expressed from plasmid pYEP96-U, which provides wt Ub
levels (Fig. 2A) (69). In doa4 cells with supplemented Ub, all
forms of BMV RNA, including positive- and negative-strand
RNA3 and positive-strand RNA4, accumulated to levels sim-
ilar to those in wt yeast cells harboring pYEP96-U (Fig. 2B).
Similar to the maximum complementation achieved by expres-
sion of wt Doa4p (Fig. 1B), supplementation with Ub restored
BMV RNA replication to 66% of that in wt cells, suggesting
that a Ub-related pathway or pathways may be responsible for
most or all inhibition of BMV RNA replication in doa4 cells.
BMV RNA replication deficiency in bro1 cells is linked to
Doa4p activity and decreased free Ub. Like DOA4, BRO1 was
implicated in BMV RNA replication in a prior yeast deletion
library screen (38). We found in repeated experiments that
replication of wt BMV RNA3 was inhibited in bro1 cells by
2.5- to 4-fold (Fig. 3A), confirming the BRO1 dependence of
BMV replication and showing that this effect was independent
of the RLuc reporter used in the original primary screening.
Bro1p has multiple functions in the MVB pathway, including
activating Doa4p’s deubiquitinase function and contributing to
Doa4p recruitment to the MVB pathway (4, 59). Bro1p con-
tributes to Doa4p recruitment by an interaction between their
N termini, while Bro1p’s crucial stimulation of Doa4p’s deu-
biqutinase activity is mediated by interaction of the Bro1p C
terminus with the Doa4p C-terminal catalytic domain (4, 44,
49, 59). Disruption of this C-terminal Bro1-Doa4p interaction
drastically inhibits Doa4p’s deubiquitinase and MVB cargo-
sorting functions (49, 59).
To test the possible relationship between BRO1’s effects on
BMV RNA replication and DOA4, we performed complemen-
tation tests with the wt BRO1 allele and selected BRO1 mu-
tants. The bro1-2 mutant has a Q8203Stop substitution that
deletes the C-terminal 25 amino acids of Bro1p, blocks Doa4p
deubiquitinase activation, and produces multiple phenotypes
paralleling those of doa4 cells (59). As expected, expressing
wt BRO1 in bro1 cells complemented the defect in BMV
RNA replication (Fig. 3A). Unlike wt Bro1p, expression of
bro1-2 from a low-copy-number plasmid had little or no sig-
nificant effect on RNA3 replication, while expression of bro1-2
from a high-copy-number plasmid inhibited the already low
BMV RNA replication a further 2-fold (Fig. 3B). The negative
effects of overexpression of bro1-2, whose N terminus interacts
with and recruits Doa4p without activation (59), might result
from suppression of the low basal activity of Doa4p or from
nonproductive sequestration of Doa4p from other roles on the
proteasome and other sites (50).
To further assess the importance of Bro1p-mediated Doa4p
deubiquitinase activation for BMV RNA replication, we also
tested the converse approach of disrupting this activation by
FIG. 2. Supplemented ubiquitin complements BMV RNA replica-
tion defect in doa4 cells. (A) Reduced levels of free Ub are comple-
mented by supplemented Ub. Total protein extraction and Western
blotting were done as in Fig. 1 with monoclonal anti-Ub or anti-Pgk1p
antibodies. (B) Supplemented Ub restores BMV RNA replication to
close to wt levels. Ub was expressed from plasmid pYEP96-U under
the control of the copper promoter and grown in medium lacking
copper. RNA extraction and Northern blotting were done as in Fig. 1.
FIG. 3. Inhibited BMV RNA replication in bro1 cells correlates
with a lack of Doa4p’s enzymatic activity and a decrease in free Ub
levels. (A) Inhibited BMV RNA replication is restored by supplemen-
tation with wt Bro1p in bro1 cells. (B) BMV RNA replication is
related to the levels of free Ub in bro1 cells. The bro1-2 mutant was
expressed from either a low- or high-copy-number plasmid, and mu-
tant bro1-C was expressed from a low-copy-number plasmid in bro1
cells. Note that the anti-Bro1p antiserum did not detect bro1-C. comp.,
complementing. (C) The functional interaction between the C termini
of Doa4p and Bro1p is required for BMV RNA replication. The
doa4AAFA mutant, which does not interact with Bro1p or support cargo
sorting and deubiquitination, did not restore BMV RNA replication in
doa4 cells. Accumulation of BMV RNAs and Ub, Bro1p, and Pgk1p
levels were detected as in Fig. 1.
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mutating DOA4 in the presence of wt BRO1. The DOA4 allele
used was doa4AAFA, which substitutes AAFA for a C-proximal
YPFL motif (aa 826 to 829) essential for the Doa4p-Bro1p
interaction that stimulates Doa4p’s enzymatic activity (59).
The doa4AAFA mutant stably accumulates in cells, and like
green fluorescent protein (GFP)-tagged wt Doa4p, GFP-
tagged doa4AAFA properly localizes to MVBs (59). Unlike wt
DOA4, however, expressing doa4AAFA in doa4 cells did not
complement the defect in BMV RNA replication (Fig. 3C).
Next we expressed in bro1 cells a C-terminal fragment of
Bro1p comprising aa 692 to 844, which lacks the N-terminal
Bro1p sequence that facilitates Doa4p recruitment to MVB
sites but retains all sequences needed to bind and activate
Doa4p’s C-terminal deubiquitinase domain (59). This C-ter-
minal Bro1p fragment complemented BMV RNA replication
nearly as efficiently as wt Bro1p (Fig. 3A and B).
Thus, the results with all three mutants were consistent with
Bro1p activation of Doa4p deubiquitinase function being the
major if not sole contribution of Bro1p to BMV RNA repli-
cation. This conclusion was further underscored by Western
blots showing that, as in doa4 cells (Fig. 2B), free Ub levels in
bro1 cells were greatly reduced relative to those in wt cells
(Fig. 3B) (4). Moreover, bro1-2 expression, which did not re-
store BMV RNA replication, did not restore free Ub levels,
whereas bro1-C expression stimulated BMV RNA replication
and free Ub levels in parallel (Fig. 3B). Since multiple, inde-
pendent findings implied that deletion of Bro1p affected BMV
RNA replication indirectly, through the loss of its stimulating
effect on Doa4p deubiquitinase, we next concentrated on how
loss of Doa4p function inhibited BMV RNA replication.
Doa4p is not required for early steps of BMV RNA replica-
tion. Loss of Doa4p or its activity increases the half-life of
many cellular proteins (50, 51). Therefore, we checked
whether deletion of DOA4 affects the accumulation of BMV
replication proteins 1a and 2apol. Western blotting showed that
1a and 2apol levels were unaffected in doa4 cells (Fig. 4A),
indicating that the BMV RNA replication defect in doa4 cells
is not due to altered accumulation or balance of the viral
replication proteins.
BMV 1a recruits viral RNA replication templates into a
membrane-associated, RNase-resistant state with a likely phys-
ical location inside the viral spherules (63). This is reflected by
a dramatic 8- to 20-fold increase in viral RNA template accu-
mulation depending on the amount of 1a protein expressed
(28, 63). BMV genomic RNA3 accumulation in the presence of
1a increased 15-fold in doa4 cells, very similar to the 13-fold
increase in wt cells (Fig. 4B), indicating that recruitment of
viral RNA replication templates was not affected by deletion of
DOA4.
BMV 1a also stimulates 2apol accumulation and recruits
2apol to ER membranes through an interaction between the 1a
C terminus and 2apol N terminus (15, 31). We examined the
distribution of 2apol in doa4 cells without or with 1a by cell
fractionation and Western blotting (Fig. 4C). In doa4 cells
without 1a, 2apol was mainly detected in the membrane-de-
pleted supernatant, similar to soluble cytoplasmic protein
Pgk1p and opposite from ER marker Dpm1p, which accumu-
lates primarily in the membrane-enriched pellet fraction (Fig.
4C). As in wt cells, 2apol accumulation increased several-fold
and shifted to the membrane-enriched pellet upon 1a expres-
sion in doa4 cells, indicating that recruitment of 2apol to
membranes by 1a was not affected in doa4 cells (Fig. 4C).
Collectively, the above data indicate that in doa4 cells
BMV RNA replication was inhibited within the short interval
after 1a-mediated recruitment of RNA templates and 2apol to
the ER membrane, but before negative-strand RNA synthesis.
Activation of transcription factor Mga2p is inhibited in
doa4 cells. Pathway and literature analysis revealed that the
regulated expression of 9 fatty acid desaturase, which is re-
quired for BMV RNA replication in yeast (39, 40) and plants
(X. Wang et al., unpublished data), was a candidate pathway
connecting DOA4 function and Ub depletion to BMV RNA
replication (Fig. 1A). Fatty acid desaturase and other lipid
synthesis genes are regulated by conserved processes that re-
tain key features from yeast to Drosophila to humans, including
the proteolytic release and activation of membrane-anchored,
cytosolic transcription factors that then translocate into the
nucleus to activate transcription of lipid metabolism genes (1,
20, 56). Specifically, in yeast, 9 fatty acid desaturase gene
OLE1 and other lipid synthesis genes are regulated by the
homologous, functionally related transcription activators
Mga2p and Spt23p (75). Mga2p and Spt23p precursor forms
(p120s) are sequestered in the ER membrane through C-ter-
minal membrane-spanning domains (Fig. 1A). Upon changes
FIG. 4. DOA4 is not required for early steps of BMV RNA repli-
cation. (A) BMV 1a and 2apol accumulate to equal levels in wt and
doa4 cells. Accumulation of BMV 1a or 2apol protein was analyzed as
in Fig. 1 with anti-1a or anti-2apol antibodies. (B) BMV RNA3 is
stabilized by 1a in doa4 cells. BMV RNA3 only or RNA3 and 1a were
expressed in wt and doa4 cells. Accumulation of RNA3 was detected
by using a BMV-specific probe as in Fig. 1. (C) BMV 2apol is recruited
to the membrane fraction by 1a in doa4 cells. Yeast cells expressing
2apol only or coexpressing 2apol and 1a were spheroplasted and lysed to
yield a total protein fraction (T). The lysate was centrifuged to obtain
membrane-depleted supernatant (S) and membrane-enriched pellet
(P) fractions. Equal volumes of total, supernatant, and pellet fractions
were subjected to SDS-PAGE, and Pgk1p, Dpm1p, and BMV 2apol
were detected by using antibodies against each protein. Note that
Pgk1p is a soluble cytoplasmic protein, while Dpm1p is an ER mem-
brane protein.
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in lipid composition or environmental stresses, Mga2p and
Spt23p are mono- or oligoubiquitinated by ubiquitin ligase
Rsp5p, the C-terminal membrane anchors are recognized and
degraded by the proteasome, and their N-terminal transcrip-
tion activation domains (p90s) are released and translocated
into the nucleus to induce transcription of OLE1 and other
genes linked to lipid metabolism (Fig. 1A) (7, 8, 25, 26, 54–56,
65). Loss of Doa4p function might inhibit Mga2p and Spt23p
activation and thus OLE1 expression because consequent re-
duction of free Ub levels may inhibit Mga2p and Spt23p ubiq-
uitination. Alternatively, or in addition, since a subset of
Doa4p is associated with proteasomes (50), deletion of DOA4
might alter proteasome function and lead to inefficient Mga2p
and Spt23p processing. Moreover, as shown above, loss of
DOA4 function mirrors the effects of reduced Ole1p activity in
inhibiting BMV RNA replication at a point between RNA
replication complex assembly and negative-strand RNA syn-
thesis (40).
To compare levels of accumulation of the transcriptionally
inactive precursor p120 and processed, active p90 forms of
Mga2p and Spt23p in wt and doa4 cells, we expressed N-ter-
minally Myc-tagged Mga2p and Spt23p, allowing both p120
and p90 to be detected using an anti-Myc antibody (26, 55).
For standard growth conditions and the yeast BY4743 strain
used here, Mga2p produced a much stronger Western blot
signal and so was used for further analysis (Fig. 5). While the
levels of accumulated BMV 1a, 2apol, and host protein Pgk1p
(Fig. 4A and 5) were similar in both wt and doa4 cells,
accumulation of both the p120 and p90 forms of Mga2p de-
creased in doa4 cells. However, the decrease in accumulation
of the transcriptionally active p90 form was more dramatic
(Fig. 5A), consistent with a decrease in Mga2p processing. The
reason for the reduction in p120 levels in doa4 cells is cur-
rently unclear, but this reduction was minor (22 to 28%) com-
pared to the 80 to 90% inhibition of BMV RNA replication.
To determine if limited free Ub caused the reduced activation
of Mga2p in doa4 cells, Ub was supplemented from plasmid
pYEP96-U to wt levels (Fig. 2A). This increased accumulation
of Mga2p p90 close to wt levels (Fig. 5B), showing that the
reduced in free Ub in doa4 cells is the major cause of inhib-
ited Mga2p activation.
Inhibition of BMV RNA replication in doa4 cells is linked
to inhibition of OLE1 expression. Since Mga2p and Spt23p
regulate OLE1 transcription, we analyzed OLE1 mRNA levels.
In doa4 cells, OLE1 mRNA accumulation was typically re-
duced 3-fold or more below wt levels (Fig. 6A). We similarly
observed a 3-fold reduction of OLE1 transcript levels in cells
overexpressing RFU1 (data not shown). This is consistent with
earlier work showing that overexpression of RFU1 inhibited
Doa4p activity and decreased Ub levels (34). Plasmid-based
expression of wt DOA4 in doa4 cells restored accumulation of
OLE1 mRNA (Fig. 6A) in parallel to BMV RNA replication
(Fig. 1B). Moreover, accumulation of OLE1 mRNA was not
increased in doa4 cells expressing the enzymatically inactive
doa4C/S mutant (Fig. 6A), demonstrating a clear correlation
between Doa4p enzymatic activity, OLE1 mRNA accumula-
tion, and BMV RNA replication.
To test if decreased BMV RNA replication was directly
related to the downregulation of OLE1 activity in doa4 cells,
we provided increasing amounts of the unsaturated fatty acid
(UFA) products of OLE1 (an equimolar mixture of palmitoleic
acid and oleic acid) in the growth medium. Adding up to 2 mM
UFA did not affect the growth of wt and doa4 strains (data
not shown). Supplemented UFA did not enhance BMV RNA
replication in wt cells, but restored BMV RNA replication in a
dose-dependent manner in doa4 cells (Fig. 6B). Accumula-
tion of positive-strand viral RNA3 increased more than 3-fold
at the highest UFA concentration, to about 65% of wt RNA
replication levels. Levels of RNA4, which was more strongly
inhibited than RNA3 in doa4 cells (Fig. 1B), saw a corre-
spondingly greater 4-fold increase upon UFA addition, from
10% to 40% compared to wt levels (Fig. 6B). However, we
never observed full complementation of BMV RNA replica-
tion with addition of UFA, as can be achieved in the ole1w and
ole1 mutants (40). This implied that decreased OLE1 expres-
FIG. 5. Activation of transcription factor Mga2p is inhibited in
doa4 cells. N-terminally Myc-tagged Mga2p was expressed in wt and
doa4 cells alone in panel A or along with Ub and BMV 1a in panel
B. Accumulation of Mga2p p120 and p90 was detected with an anti-
Myc monoclonal antibody by Western blotting.
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FIG. 6. Inhibited BMV RNA replication in doa4 cells is linked to
inhibition of OLE1 expression. (A) Decreased accumulation of OLE1
mRNA correlates with defective BMV RNA replication in doa4 cells.
OLE1 mRNA was detected by Northern blotting with an OLE1-spe-
cific probe. The RNA signals were normalized to that of 18S rRNA.
(B) BMV RNA replication was measured after addition of increasing
concentrations of UFA (an equimolar mixture of palmitoleic and oleic
acids) to the yeast growth medium. Accumulation of BMV RNA was
detected as in Fig. 1. Values represent the means of four independent
repeats.
VOL. 85, 2011 HOST LIPID SYNTHESIS AND BMV RNA REPLICATION 5499
 o
n
 Septem
ber 12, 2018 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
sion only partially accounts for the inhibition of BMV RNA
replication in doa4 cells, as is addressed in the next section.
Other Mga2p-regulated genes are involved in BMV RNA
replication. Besides OLE1, whose expression has been exten-
sively studied, Mga2p and Spt23p collectively regulate at least
30 genes involved in lipid metabolism, including those synthe-
sizing fatty acids (FAS1 and ACC1), sterols (ERG1, -3, -5, and
-26), and sphingolipids (SUR1 and -4) (7). However, Mga2p
and Spt23p regulate overlapping but not exactly matching sets
of genes. While OLE1 expression is induced by either Mga2p
or Spt23p, other lipid metabolism genes, such as SUR4 and
ERG5, are preferentially induced by Mga2p (7). To test if
other Spt23p- and/or Mga2p-regulated genes besides OLE1
might be partially responsible for inhibiting BMV RNA repli-
cation in doa4 cells, we tested BMV RNA replication in
mga2 and spt23 cells. In both cell types, OLE1 transcripts
accumulated to wt levels (Fig. 7), which was expected since
either Mga2p or Spt23p is sufficient to activate OLE1 expres-
sion (75).
Despite unaltered levels of OLE1 mRNA, deletion of MGA2
inhibited BMV RNA replication by more than 5-fold, com-
pared to a mild decrease (25%) upon deletion of SPT23 (Fig.
7). This implies that one or more other genes specifically or
preferentially regulated by Mga2p play important roles in
BMV RNA replication.
DOA4-independent depletion of free Ub inhibits Mga2p ac-
tivation and BMV RNA replication. We tested if deleting free
Ub would affect Mga2p and Spt23p activation, the consequent
OLE1 expression, and BMV RNA replication as a general
phenomenon not specific to deletion or inhibition of DOA4.
Among 60 host gene deletion mutants previously found to
inhibit BMV RNA replication (38), the ufd3 and ubp6 mu-
tants have depleted free Ub levels (30, 41, 61). Ubp6p is a
deubiquitinating enzyme and an accessory component of the
proteasome (Fig. 1A) (5, 41). Ufd3p is involved in protein
turnover via an interaction with CDC48, a critical component
of a major pathway for delivering substrate proteins to protea-
somes (30, 41, 61). Ufd3p also regulates Spt23p stability (61).
Deletion of UFD3 and UBP6 may affect Spt23p and Mga2p
activation in at least two ways. First, as in doa4 cells, de-
creased free Ub levels in ufd3 and ubp6 cells may inhibit
ubiquitination and subsequent activation of Mga2p and
Spt23p. Alternatively, or in addition, deletion of UBP6 may
affect proteasome activity and thus Mga2p and Spt23p process-
ing (41), while deletion of UFD3 may affect the stability of the
processed, active Spt23p and Mga2p p90 forms (61).
Consistent with the results of Kushner et al. (38), BMV
RNA replication was inhibited in ufd3 and ubp6 mutants to
5-fold and 10- to 20-fold, respectively (Fig. 8A). Also consis-
tent with previous reports (30, 41, 61), free Ub levels were
much reduced in both ufd3 and ubp6 mutants (Fig. 8B).
While Mga2p p120 accumulated to near wt levels in ufd3 and
ubp6 mutants, Mga2p p90 was much reduced (Fig. 8B), con-
firming that Mga2p processing was inhibited.
To test if reduced Mga2p p90 accumulation and BMV RNA
replication could be restored in these mutants by supplemen-
tation with Ub, pYEP96-U was used to express Ub to wt levels
in both mutants (Fig. 8B). In ubp6 cells, providing Ub in-
creased Mga2p p90 to near wt levels. On the other hand,
supplementation with Ub only slightly increased Mga2p p90
accumulation in ufd3 cells, suggesting that deletion of UFD3
may affect both Mga2p activation and stability. Consistent with
Mga2 p90 accumulation, BMV RNA replication was restored
to wt levels in ubp6 cells but only increased from 20% to 35%
in ufd3 cells (Fig. 8A).
DISCUSSION
The RNA replication complexes of BMV and many other
positive-strand RNA viruses (17, 47, 62, 63), budding envel-
oped virions (10, 11, 48), and MVB intralumenal vesicles (27,
33, 53) are all topologically similar in being formed by invag-
inating membranes away from the cytoplasm. Just as budding
of many enveloped virions depends on MVB components,
prior genomewide screening showed that efficient BMV RNA
replication requires MVB genes (38), and recent results show
that MVB components also are transiently recruited by an-
other positive-strand RNA virus, tomato bushy stunt virus,
to peroxisome membranes, where they promote RNA rep-
lication (9).
Here we investigated how two MVB genes, the deubiquiti-
FIG. 7. BMV RNA replication is inhibited in mga2 mutant cells.
BMV components were expressed in wt, mga2, and spt23 cells.
Accumulation of BMV RNAs and OLE1 mRNA was assessed as in
Fig. 1 with BMV RNA- or OLE1-specific probes.
FIG. 8. Inhibited Mga2p activation and BMV RNA replication can
be restored or partially restored in ubp6 and ufd3 cells by supple-
mentation with Ub. (A) BMV RNA replication and (B) Mga2p acti-
vation were assessed in wt, ufd3, and ubp6 cells with or without the
addition of Ub. BMV 1a was expressed in all cells in panel B. Accu-
mulation of BMV RNAs and activation of Mga2p were analyzed as in
Fig. 1 and 5, respectively.
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nase gene DOA4 and the multifunctional gene BRO1, contrib-
ute to BMV RNA replication. The mammalian homologs of
DOA4 and BRO1 are the genes coding for Ubpy and Alix (59,
60). Notably, Alix has emerged as a key player in the MVB-
dependent budding of multiple retroviruses and some other
viruses, although the precise nature of its functions in such
viral budding remain under study (14, 46, 48). Nevertheless,
many features of BRO1/ALIX and DOA4/Ubpy function ap-
pear conserved from yeast to mammals. Among these, in par-
allel to Bro1p-mediated recruitment of Doa4p for MVB cargo
deubiquitination (59), recruitment of Bro1p homolog Alix to
HIV-1 Gag promotes Gag deubiquitination (45).
Despite the topological similarities of membrane-bound
BMV RNA replication compartments and MVB compart-
ments, we found that the roles of DOA4 and BRO1 in BMV
RNA replication were independent of the protein- and mem-
brane-sorting functions of the MVB pathway. Rather, as de-
tailed below, defects in Doa4p or Bro1p or their interactions
disrupted BMV RNA replication by depleting free Ub levels
and thereby inhibiting induction of OLE1 fatty acid desaturase
and other lipid synthesis genes required by BMV RNA repli-
cation (Fig. 2, 5, 6, and 7). Possible implications of these results
for virus control are also considered.
DOA4-, BRO1-, and Ub-dependent activation of lipid syn-
thesis genes. Multiple results showed that the BMV RNA
replication defects in doa4 and bro1 cells were linked to free
Ub levels and the activation of lipid synthesis/modification
genes, but not to the membrane-shaping functions of the MVB
pathway. BMV RNA replication required Doa4p with a cata-
lytically active deubiquitinase (Fig. 1B), a function that is dis-
pensable for invaginating intralumenal vesicles to form MVBs
(59) but essential to maintain normal free Ub levels (69). In
keeping with this, across varied circumstances in doa4 cells
there was a tight correlation between BMV RNA replication
and the levels of free Ub (Fig. 2), the Ub-dependent activation
of lipid synthesis regulator Mga2p (Fig. 5B), and the accumu-
lation of OLE1 fatty acid desaturase mRNA (Fig. 6A). The
mechanistic linkage between these observations was confirmed
by showing that the BMV RNA replication defect in doa4
cells was complemented by supplementation of free Ub levels
(Fig. 2), which restored activation of Mga2p (Fig. 5B), or by
feeding the UFA products of Ole1p fatty acid desaturase (Fig.
6B), thus bypassing Ub levels, Mga2p activation, and OLE1
expression.
BRO1, which was also required for BMV RNA replication,
provides multiple functions to the MVB pathway. For example,
unlike DOA4, deletion of BRO1 blocks the formation of nor-
mal MVB membrane compartments, yielding instead aberrant
“class E” endosomes that are flattened cisternae without in-
tralumenal vesicles (27, 33, 53). However, using mutations that
selectively ablate specific functions, we found that BRO1 con-
tributes to BMV RNA replication indirectly by interacting with
Doa4p to stimulate its deubiquitinase activity and the accumu-
lation of free Ub (Fig. 3B). Thus, in bro1 cells, BMV RNA
replication was restored by expressing a Bro1p C-terminal
fragment, bro1-C, that neither supports formation of func-
tional MVB membrane compartments nor facilitates Doa4p
recruitment to MVB sites, but interacts with and activates the
Doa4p catalytic domain (59) and stimulates free Ub levels
(Fig. 3B). Conversely, BMV RNA replication in bro1 cells
was not restored by expressing the bro1-2 C-terminal-trunca-
tion mutant (Fig. 3B), which supports intralumenal vesicle and
MVB compartment formation but does not stimulate Doa4p’s
deubiquitinase activity (59). In keeping with this, the doa4AAFA
mutant, which disrupts the Doa4p side of the activating inter-
action with wt Bro1p, similarly blocked BMV RNA replication
in doa4 cells (Fig. 3C). Thus, Doa4p’s deubiquitinating activ-
ity, not Bro1p’s possible role in inducing membrane curvature,
is required for supporting BMV RNA replication.
Thus, all of the above results indicated that DOA4 and
BRO1 primarily affected BMV RNA replication through their
effects on free Ub levels and the Ub-dependent activation of
lipid synthesis regulators Mga2p and Spt23p. While this un-
derlying linkage between Ub levels, lipid synthesis, and BMV
RNA synthesis was clear, some variations were noted between
the levels of free Ub and associated effects on BMV RNA
replication in the doa4 and bro1 mutants (Fig. 2A and 3B).
One likely explanation for some variations in both Ub levels
and inhibition of BMV RNA replication would be variations in
culture growth conditions, which alter free Ub levels in the
doa4mutant. Specifically, Ub levels in the doa4 strain reach
1/3 of those in wt cells during log-phase growth, but fall to
only 1/10 of those in wt cells in the stationary phase (69).
We further tested and validated the linkage of free Ub
levels, lipid synthesis activation, and BMV RNA replication by
using mutations in other host genes that modulate free Ub
levels. As predicted, overexpressing RFU1, which inhibits
Doa4p’s enzymatic activity and depletes free Ub (34), mark-
edly reduced OLE1 transcript levels (results not shown) and
BMV RNA replication in wt cells (Fig. 1C). Moreover, DOA4-
independent inhibition of BMV RNA replication in ubp6 and
ufd3 cells also strongly correlated with decreased free Ub
levels and deficient Mga2p activation (Fig. 8).
In both plant cells and yeast, subgenomic RNA4 accumula-
tion is much more sensitive than genomic RNA3 accumulation
to slight variations in inoculation, growth conditions, host ge-
notype, etc. In keeping with this, DOA4 deletion inhibited
RNA4 accumulation more significantly than RNA3 accumula-
tion, as shown in Fig. 1B and elsewhere. Thus, while both
RNA3 synthesis and RNA4 synthesis are inhibited by DOA4
deletion and restored by supplying Ub or unsaturated fatty
acids, they do have different sensitivities to these and other
effects.
Mga2p-regulated genes beyond OLE1 contribute to BMV
RNA replication. OLE1 mutations inhibit BMV RNA replica-
tion 20-fold, but are completely complemented by supplying
the UFA products of OLE1 in the medium (40). In contrast,
the BMV RNA replication defect in doa4 cells was only
partially complemented by supplementing cells with UFA (Fig.
6B), implying that OLE1 was not the only BMV-required gene
affected. Consistent with this, Mga2p and Spt23p control many
genes involved in fatty acid, sphingolipid, and sterol metabo-
lism (7), and BMV RNA replication depends on many lipid
synthesis modification and transport genes beyond OLE1 (38).
Furthermore, although both accumulated wt levels of OLE1
mRNA, BMV RNA replication was inhibited 5-fold in mga2
cells but by only 25% in spt23 cells.
Accordingly, genes other than OLE1 that are preferentially
controlled by Mga2p might account for the residual inhibition
of BMV RNA replication that is not complemented by UFA
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feeding (Fig. 7). Mga2p was predominantly expressed over
Spt23p in the BY4743 strain used here (Fig. 5B), which may
partly account for the greater defect in mga2 cells. Addition-
ally, the promoters of multiple lipid metabolism genes are
more strongly bound by Mga2p than Spt23p, including genes
involved in synthesizing sterols important for the replication of
other positive-strand RNA viruses, including hepatitis C virus
(HCV) (73) and tomato bushy stunt virus (64).
Relevance to bromovirus replication in plants. The results
presented here obtained with yeast reveal new aspects of host
function required for BMV RNA replication and interconnec-
tions between key pathways required by BMV, including un-
saturated fatty acid synthesis and Ub-dependent proteasomal
processing. As noted above, these pathways show broad con-
servation across eukaryotes, and other recent results from our
laboratory show that BMV RNA replication in plants also
depends critically on both of these pathways. We find, e.g., that
inhibiting of proteasome function suppresses BMV RNA rep-
lication in barley protoplasts (B. Gancarz and P. Ahlquist,
unpublished data), confirming that proteasome-dependent
pathways are essential for BMV replication in cells of a natural
plant host. Moreover, in a particularly direct connection to the
present results, we find that knocking down fatty acid desatu-
rase activity dramatically inhibits BMV RNA replication in N.
benthamiana (X. Wang, A. Diaz, and P. Ahlquist, unpublished
data). Thus, as was originally found (39, 40) and further ex-
tended here using yeast, membrane lipid composition and un-
saturated fatty acids in particular are also crucial for BMV
RNA replication in a plant host. Together, these results and
recent studies of the involvement of sterol synthesis in tom-
busvirus replication (64) show that multiple membrane-associ-
ated pathways linked to virus replication in yeast are also
essential in natural hosts.
Relationship to other positive-strand RNA viruses. Mem-
brane lipid synthesis and composition are critical for RNA
replication by many if not all positive-strand RNA viruses (13,
32, 38, 64, 66, 72–74). Inhibition of one or more aspects of fatty
acid synthesis, e.g., inhibits replication of many viruses, includ-
ing poliovirus (23), Semliki Forest virus (52), cowpea mosaic
virus (12), BMV (39, 40), HCV (32), and Drosophila C virus
(16). Similarly, cholesterol metabolic pathways are required by
many viruses, such as HCV, for entry, RNA replication, and
egress (73). Accordingly, the results presented here with a
variety of host genes highlight broader potentials to control
viral RNA replication and other aspects of infection by manip-
ulating lipid synthesis and its regulation in novel ways. Ad-
vancement of understanding of the lipid dependencies of spe-
cific virus replication steps and the cellular regulatory circuits
that control different aspects of lipid metabolism and their
interaction with other pathways should enhance the potential
for virus control while minimizing host toxicity. The wide im-
portance of these pathways suggests the possibility of ap-
proaches effective against multiple viruses, and the broad con-
servation of many features of lipid regulation from yeast to
humans (1, 20, 56) should facilitate generalizing such strategies
across a range of practically important hosts.
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